Le Lézard
Classified in: Health
Subject: SVY

Global Synthetic Sweeteners Industry Outlook to 2030: Focus on Aspartame, Acesulfame K, Saccharin, Sucralose, Neotame, and More


DUBLIN, Feb. 24, 2020 /PRNewswire/ -- The "Synthetic Sweeteners Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global synthetic sweeteners market was worth $54.37 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 5% and reach $65.73 billion by 2023.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider synthetic sweeteners market, and compares it with other markets.

Rising health awareness among global consumers contributed to the growth of the synthetic sweeteners market. The increased incidences of individuals suffering from heart diseases, diabetes, and obesity will eventually force people to lead a healthier lifestyle. For instance, in 2016, according to the 'World Health Organization' (WHO), 31% of world's population died due to cardiovascular diseases.

The survey also states that, people with diabetes increased from 108 million in 1980 to 422 million in 2014, and the global obesity has almost tripled since 1975. In 2018, the American Heart Association (AHA) and the American Diabetes Association (ADA) has given acceptance in the use of artificial sweeteners, instead of sugar to fight against obesity, metabolic syndrome and diabetes, factors causing heart diseases. The rising health awareness among global consumers increased the demand for synthetic sweeteners during the historic period, driving the market.

The long term use of synthetic sweeteners can cause diabetes and is expected to limit the growth of the synthetic sweeteners market. It increases the risk of obesity and heart diseases. Long-term use of artificial sweeteners changes taste buds over time, resulting in persistent craving for excessively sweet foods. Due to this, nutrient deficiencies and weight gain are on the rise. It could lead to severe long-term illnesses such as headaches, dizziness, rash, bloating, nausea, diarrhea, and digestive problems.

For instance, in 2018, Brian Hoffmann, an assistant professor at the Medical College of Wisconsin and Marquette University, in his new research study, states that long-term use of synthetic sweeteners could lead to metabolic disorders such as diabetes and obesity. Additionally, in the year 2017, a study from the 'Canadian Medical Association Journal', also explains non-nutrient sweeteners such as aspartame, sucralose and stevia may increase the risk of obesity and its related effects over long-term use. Long-term use of synthetic sweeteners has a negative impact on synthetic sweeteners market resulting in obesity and heart diseases.

Sucralose-based sweeteners are increasingly being used as applications in the food industry. Sucralose is more sweet than sugar and is a low-calorie ingredient that does not cause dental cavity. Growing concerns of cardiovascular disorders due to increased consumption of sugar-based foods are encouraging the use of artificial sweeteners such as sucralose. Additionally, declining production and rising sugar prices worldwide are also encouraging the use of sucralose-based sweeteners. These sweeteners are the major substitutes of sugar in carbonated beverages, juices, dairy products, sugar-free chewing gums, confectionery, and bakery goods. For instance, in 2017, in the U.S., PepsiCo is using sucralose-based sweeteners by replacing aspartame in diet pepsi.

In September 2018, Firmenich SA, a Switzerland-based company specialized in manufacturing flavors for beverages, sweets and other foods, acquired Senomyx, Inc. for an undisclosed amount. The acquisition helped Firmenich SA in adding Senomyx's leading flavor innovations and strong natural ingredients to their taste platform. Senomyx, Inc. is a USA-based biotechnology company that specializes in flavor ingredients and natural high intensity sweeteners.

The synthetic sweeteners market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. In 2019, Asia Pacific accounts for around 55% of the market. The synthetic sweeteners market in Middle East is forecasted to register the highest CAGR during 2019-2023.

Major players in the market are Cargill Inc., Archer Daniels Midland, Ingredion Inc., Roquette, Ajinomoto Co. Inc., JK Sucralose Inc., Dupont, Merisant Company (subsidiary of MacAndrews & Forbes Incorporated), Celanese Corporation, McNeil Nutritionals

Key Topics Covered

1. Executive Summary

2. Synthetic Sweeteners Market Characteristics

3. Synthetic Sweeteners Market Size And Growth
3.1. Global Synthetic Sweeteners Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Synthetic Sweeteners Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Synthetic Sweeteners Market Segmentation
4.1. Global Synthetic Sweeteners Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

4.2. Global Synthetic Sweeteners Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

4.3. Global Synthetic Sweeteners Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5. Synthetic Sweeteners Market Regional And Country Analysis
5.1. Global Synthetic Sweeteners Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Synthetic Sweeteners Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/n1fms4

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 10:15
Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Kwan-Ho "Alex" Chung, Ph.D. has joined the firm's Intellectual Property practice group and Life Sciences industry team in Washington, D.C. Chung was most recently a partner at...

at 10:14
Public health researchers have a new, powerful tool from data and AI provider SAS to analyze the National Institutes of Health's All of Us Research Program's large and diverse data set. The NIH has added SAS Analytics Pro on SAS® Viya® to the All of...

at 10:10
HighField Biopharmaceuticals, a clinical stage immuno-oncology company using lipid-based therapeutics to treat cancer, announced today that two HighField abstracts have been accepted with one poster presentation at the American Society of Clinical...

at 10:10
Bicycle Therapeutics plc , a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the acceptance of two abstracts for poster presentation...

at 10:10
Dizal (SSE:688192), a biopharmaceutical company committed to developing groundbreaking new medicines for the treatment of cancer and immunological diseases, announced today that two abstracts featuring the latest data on sunvozertinib in non-small...

at 10:07
The American Association of Critical-Care Nurses (AACN) has published "AACN Standards for Appropriate Staffing in Adult Critical Care," the specialty's first, action-oriented staffing standards. Appropriate staffing has long been one of the "AACN...



News published on and distributed by: